RE:Patients 20 & 21Hi 99942Apophis - You're right - as of May 28, 2021 only 19 patients had been treated and on June 11, 2021 it was announced that the 20th patient had been treated. So the 20th patient won't reach 450 days until somewhere between August 21st and September 4th 2022.
In the MD&A before showing the table of results for the first 20 patients it says:
"An analysis of the first 20 patients treated in Study II (completed all assessment visits), provides the following interim analysis:" Patient 20 has not yet completed his/her 450 day assessment visit.
What could this mean? Could this be a table of the first 20 patients that have received all of the assessment visits they are eligible for? In other words, the first 20 patients who are not "no response" and so are no longer being assessed?
99942Apophis wrote: Patient 20 announced June 11/2021 just hit 360 days and although patients 21 to 24 were announced August 30/2021 my guesstimate is patient 21 will hit 360 days very close to the AGM.
By years end (2022) we should see 24 patients hitting 450 days with a strong possibility of patient 25 getting in too.